SAN FRANCISCO — Struggling blood test startup Theranos Inc. on Monday was hit with a class action lawsuit filed on behalf of investors who sank hundreds of millions of dollars to buy shares in the privately held company once valued at $9 billion.
The named plaintiffs in the federal lawsuit are Robert Colman, who The Wall Street Journal has characterized as a Silicon Valley dealmaker, and Hilary Taubman-Dye, a California resident who invested via SharePost, an online service that allows people to buy and sell shares of nonpublic companies.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
